Mar HaeusslerExecutive Director, Transfer Pricing at NOVARTIS
Agenda Sessions
Amount B/Simplified and Streamlined Approach - Implications & Scope
, 10:10View SessionValuation of IP & Approaches to Determining an Arm’s Length Exit Charge
, 14:40View Session